I believe Yahoo is doing the deleting. There were comments from Sept. 27 posted until a few days ago, and there were several postings during the first five or six days of October. Now they are gone.
I don't know if this is a one-off situation or a trend, but TASR sold hundreds of prosecutors' licenses to the San Diego County DA. These kind of products are very profitable, with most of the money going straight to the bottom line.
3D printer manufacturers are slow growing as customers are waiting for new models to come out in 2016 that have as much as 20x the throughput of older models.
If you expected it to rise yesterday, why did you have a limit order to sell at 19? You just did a stop-gain trade (most people do stop-loss trades). Invest, not trade. The only thing you're doing is increasing your trading costs. In a few years, CFMS will be doing a lot more than just knee replacements. They're working on FDA approval for a hip replacement now and there may be shoulder, elbow, wrist and ankle replacements later. And new 3-D printers are coming out next year with speeds up to 20 times faster than current 3-D printers (the stock of 3-D printer manufacturers are down because buyers are waiting for the new models). With new printers, their new facility will have increased throughput to do more replacements for years longer than they expected when they started construction of the facility.
Sept. 25 WSJ notes JNJ will be using IBM's Watson computer to help patients with knee replacements with a coaching app in the recovery process. They hope to have a working prototype in the 4Q. IBM acquired a healthcare records company with a database of 315 billion data points representing more than 50 million people.
Failures of what? It was water on the instrumentation, not on the implant. There has been no mention of infected implants. 600 were used while 350 of the 950 recalled were sitting on the shelf. Where do you get "over"?
A strange report, briefly discussing two companies in two segments of the medical industry (replacements and blood systems).
$9K seems high unless video storage is included. What's the time frame?
(1) Those that wanted to sell have completed their selling, putting less downward pressure on the price.
(2) Shorts are covering, impacting the upside of the price.
Now, 19 legal firms have announced they intend to file, or have filed, file class-action lawsuits against CFMS. Given that the problem may be over (see recent posts), maybe they will have better luck going after Volkswagen for INTENTIONAL fraud of U.S. emission standards. The manufacturing glitch at CFMS's new facility was an honest mistake. CFMS voluntarily (i.e., not forced to) recalled the suspicious replacement systems and their instrumentation. In three months this will be forgotten, just like Intel's microchip glitch in the mid-1990s (there were no reported lawsuits against Intel at the time - again, an honest mistake that was corrected promptly). That 19 legal firms are involved indicates how slow the legal profession is currently. They are grasping at anything that may generate revenue. Such desperation clouds the mind and results in questionable lawsuits that may be considered frivolous, just like Republicans trying to attach human rights to an ocra whale in San Diego for killing its trainer so they could kill it (the judge dismissed the suit, saying the whale wasn't a human). If these lawsuits continue, they will be consolidated down to one. It would be interesting to see the infighting among these law firms to see which one represents shareholders.
Your first line suggests they were installed in November. The rest of your lines suggest you were waiting for them to be installed. Which is it?
There's little moderation if they write off $29M of inventory in the latest quarter. They should be able to control inventory better than that. Sales regions are declining from 150 to 90 to 50? Is anybody in control there?
It depends on the conditions. This was a manufacturing glitch at a new facility. It's not like tax evasion (UBS) or hiding the truth that led to 127 deaths (the GM penalty of $900M is insufficient; after Pfizer illegally marketed one of the products for the FIFTH time, the FDA penalized them for $2 billion). Maybe, now, Pfizer management gets it.